Laboratory Accreditation for Analyses of Foods; Extension of Comment Period, 11893-11894 [2020-03944]

Download as PDF 11893 Federal Register / Vol. 85, No. 40 / Friday, February 28, 2020 / Proposed Rules By direction of the Commission. Commissioner Glick is dissenting with a separate statement attached. Issued: February 20, 2020. Kimberly D. Bose, Secretary. United States of America Federal Energy Regulatory Commission Docket No. Revisions to Indexing Policies and Page 700 of FERC Form No. 6 .................................................................................................. Petition for a Rulemaking of the Liquids Shippers Group, Airlines for America, and the National Propane Gas Association .......... jbell on DSKJLSW7X2PROD with PROPOSALS GLICK, Commissioner, dissenting: I am dissenting from today’s order withdrawing the Advance Notice of Proposed Rulemaking (ANOPR) and denying shippers’ petition for rulemaking, because the Commission must do more to ensure shippers and the Commission have the information necessary to protect against unjust and reasonable oil pipeline rates.26 It is especially critical to provide shippers with adequate transparency into pipeline costs, given that the Commission has chosen to rely solely on shippers to ensure that pipeline rates are just and reasonable, as required by the Interstate Commerce Act (ICA).27 The Commission has the statutory authority to initiate its own cost-of-service investigations into pipeline rates but has for decades chosen not to do so.28 Instead of summarily terminating this proceeding, the Commission should have proceeded with a Notice of Proposed Rulemaking aimed at enhancing pipelines’ data reporting requirements, so that the information available to shippers and the public is useful both in the evaluation of index filings and for cost-of-service rate challenges. The Commission is responsible for ensuring that the rates oil pipelines charge are just and reasonable. Through the ANOPR, the Commission sought to enhance the transparency of information reported on FERC Form No. 6, page 700, to ensure the public can effectively assess the reasonableness of oil pipeline rates and so that the Commission can ‘‘better fulfill its statutory obligations under the ICA.’’ 29 As the Commission explained, a pipeline’s costs associated with providing one service may be ‘‘fundamentally different’’ from the costs of providing another service.30 Because the 26 Revisions to Indexing Policies and Page 700 of FERC Form No. 6, 170 FERC ¶ 61,134 (2020) (Withdrawal Order). 27 49 App. U.S.C. 1(5) (1988). 28 As the Commission explained in Order No. 561, the Commission retains the responsibility to ensure rates are just and reasonable under the ICA, and for this reason it ‘‘will not promulgate an explicit bar to Commission-initiated rate investigations.’’ Revisions to Oil Pipeline Regulations Pursuant to the Energy Policy Act of 1992, Order No. 561, FERC Stats. & Regs. ¶ 30,985, at 30,967 (1993). Nonetheless, the Commission explained that, while it ‘‘believes it is advisable to retain the authority to investigate a rate on its own motion, it should make clear that it does not contemplate invoking such authority except in the most unusual circumstances.’’ Id. 29 Revisions to Indexing Policies and Page 700 of FERC Form No. 6, 157 FERC ¶ 61,047, at P 5 (2016) (ANOPR Order). 30 Id. P 27. VerDate Sep<11>2014 17:07 Feb 27, 2020 Jkt 250001 Commission’s regulations only require pipelines to report company-wide data, the information currently available to shippers is at best, a rough approximation of the costs underlying a particular shipper’s rates. In the ANOPR, the Commission proposed to require pipelines to report more granular data, so that shippers could use the information to compare the rate they are being charged ‘‘with costs that are more closely associated with that particular rate.’’ 31 The Commission stated that this information ‘‘would be useful both in the evaluation of index filings . . . and for costof-service rate challenges to oil pipeline rates.’’ 32 However, in today’s order, the Commission does a complete about-face, withdrawing its proposal on grounds that it is ‘‘unnecessary and inconsistent’’ with the purposes of a ‘‘preliminary screen.’’ 33 The Commission fails to explain how the information currently available to shippers is adequate for purposes of monitoring and challenging the justness and reasonableness of oil pipeline rates, except to say that shippers can use ‘‘their knowledge of the pipeline system to support any cost-ofservice complaints.’’ 34 Moreover, while the Commission notes the potential cost impact this ANOPR proposal may have on oil pipeline companies, it appears to give scant consideration to the benefit this additional information would have for ratepayers and the public. Absent greater transparency into the costs underlying a specific rate, shippers are left with no more than a pitiable choice between the rate charged and a costly fishing expedition to obtain the information they need to challenge the rate in the first place. In light of the Commission’s historic practice of relying on shippers to challenge rates rather than initiate its own investigations where the rates charged may no longer be just and reasonable, it is imperative that the Commission ensure shippers have access to the information they need to carry out this essential check. In today’s order, the Commission fails to fulfill its last remaining responsibility to ensure oil pipeline rates remain just and reasonable. For these reasons, I respectfully dissent. Richard Glick. Commissioner. [FR Doc. 2020–04069 Filed 2–27–20; 8:45 am] BILLING CODE 6717–01–P 31 Id. 32 Id. 33 Withdrawal 34 Id. PO 00000 Order, 170 FERC ¶ 61,134 at P 6. P 7. Frm 00028 Fmt 4702 Sfmt 4702 RM17–1–000 RM15–19–000 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Parts 1, 11, 16, and 129 [Docket No. FDA–2019–N–3325] RIN 0910–AH31 Laboratory Accreditation for Analyses of Foods; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. Proposed rule; extension of comment period for the proposed rule and for its information collection provisions. ACTION: The Food and Drug Administration (FDA or we) is extending the comment period for the proposed rule, and for the information collection related to the proposed rule, entitled ‘‘Laboratory Accreditation for Analyses of Foods’’ that appeared in the Federal Register of November 4, 2019. We are taking this action in response to a request for an extension to allow interested persons additional time to consider the proposal. We also are taking this action to keep the comment period for the information collection provisions associated with the rule consistent with the comment period for the proposed rule. DATES: FDA is extending the comment period on the proposed rule published November 4, 2019 (84 FR 59452). Submit either electronic or written comments on the proposed rule by April 6, 2020. Submit comments on information collection issues under the Paperwork Reduction Act of 1995 (PRA) by April 6, 2020 (see the ‘‘Paperwork Reduction Act of 1995’’ section). ADDRESSES: You may submit comments as follows. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before April 6, 2020. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of April 6, 2020. Comments SUMMARY: E:\FR\FM\28FEP1.SGM 28FEP1 11894 Federal Register / Vol. 85, No. 40 / Friday, February 28, 2020 / Proposed Rules received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. jbell on DSKJLSW7X2PROD with PROPOSALS Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ Instructions: All submissions received must include the Docket No. FDA– 2019–N–3325 for ‘‘Laboratory Accreditation for Analyses of Foods.’’ Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday. • Confidential Submissions—To submit a comment with confidential VerDate Sep<11>2014 17:07 Feb 27, 2020 Jkt 250001 information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ‘‘confidential.’’ Any information marked as ‘‘confidential’’ will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA’s posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https:// www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https:// www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Timothy McGrath, Staff Director, Food and Feed Laboratory Operations, Office of Regulatory Affairs, Food and Drug Administration, 12420 Parklawn Dr., Rm. 3142, Rockville, MD 20857, 301– 796–6591, email: timothy.mcgrath@ fda.hhs.gov. With regard to the information collection: Domini Bean, Office of Operations, Food and Drug Administration, Three White Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 301–796– 5733, email: PRAStaff@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In the Federal Register of November 4, 2019 (84 FR 59452), we published a proposed rule entitled ‘‘Laboratory Accreditation for Analyses of Foods’’ with a 120-day comment period on the provisions of the proposed rule and on the information collection provisions that PO 00000 Frm 00029 Fmt 4702 Sfmt 4702 are subject to review by the Office of Management and Budget (OMB) under the PRA (44 U.S.C. 3501–3521). FDA has received a request for a 30day extension of the comment period on the proposed rule to allow interested persons additional time to consider the proposal. FDA has considered the request and is granting the extension of the comment period to allow interested persons additional opportunity to consider the proposal. We also are extending the comment period for the information collection provisions to make the comment period for the information collection provisions the same as the comment period for the provisions of the proposed rule. To clarify, FDA is requesting comment on all issues raised by the proposed rule. The Agency believes that this extension allows adequate time for any interested persons to fully consider the proposal and submit comments. Dated: February 21, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–03944 Filed 2–27–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF THE TREASURY Alcohol and Tobacco Tax and Trade Bureau 27 CFR Part 9 [Docket No. TTB–2020–0002; Notice No. 187] RIN 1513–AC54 Proposed Establishment of the Verde Valley Viticultural Area Alcohol and Tobacco Tax and Trade Bureau, Treasury. ACTION: Notice of proposed rulemaking. AGENCY: The Alcohol and Tobacco Tax and Trade Bureau (TTB) proposes to establish the approximately 200 squaremile ‘‘Verde Valley’’ viticultural area in Yavapai County, Arizona. The proposed viticultural area is not located within, nor does it contain, any other established viticultural area. TTB designates viticultural areas to allow vintners to better describe the origin of their wines and to allow consumers to better identify wines they may purchase. TTB invites comments on this proposed addition to its regulations. DATES: Comments must be received by April 28, 2020. ADDRESSES: You may electronically submit comments to TTB on this proposal, and view copies of this SUMMARY: E:\FR\FM\28FEP1.SGM 28FEP1

Agencies

[Federal Register Volume 85, Number 40 (Friday, February 28, 2020)]
[Proposed Rules]
[Pages 11893-11894]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03944]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 1, 11, 16, and 129

[Docket No. FDA-2019-N-3325]
RIN 0910-AH31


Laboratory Accreditation for Analyses of Foods; Extension of 
Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; extension of comment period for the proposed 
rule and for its information collection provisions.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is extending the 
comment period for the proposed rule, and for the information 
collection related to the proposed rule, entitled ``Laboratory 
Accreditation for Analyses of Foods'' that appeared in the Federal 
Register of November 4, 2019. We are taking this action in response to 
a request for an extension to allow interested persons additional time 
to consider the proposal. We also are taking this action to keep the 
comment period for the information collection provisions associated 
with the rule consistent with the comment period for the proposed rule.

DATES: FDA is extending the comment period on the proposed rule 
published November 4, 2019 (84 FR 59452). Submit either electronic or 
written comments on the proposed rule by April 6, 2020. Submit comments 
on information collection issues under the Paperwork Reduction Act of 
1995 (PRA) by April 6, 2020 (see the ``Paperwork Reduction Act of 
1995'' section).

ADDRESSES: You may submit comments as follows. Please note that late, 
untimely filed comments will not be considered. Electronic comments 
must be submitted on or before April 6, 2020. The https://www.regulations.gov electronic filing system will accept comments until 
11:59 p.m. Eastern Time at the end of April 6, 2020. Comments

[[Page 11894]]

received by mail/hand delivery/courier (for written/paper submissions) 
will be considered timely if they are postmarked or the delivery 
service acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to https://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper 
submissions): Dockets Management Staff (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets 
Management Staff, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2019-N-3325 for ``Laboratory Accreditation for Analyses of Foods.'' 
Received comments, those filed in a timely manner (see ADDRESSES), will 
be placed in the docket and, except for those submitted as 
``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. 
and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will 
review this copy, including the claimed confidential information, in 
its consideration of comments. The second copy, which will have the 
claimed confidential information redacted/blacked out, will be 
available for public viewing and posted on https://www.regulations.gov. 
Submit both copies to the Dockets Management Staff. If you do not wish 
your name and contact information to be made publicly available, you 
can provide this information on the cover sheet and not in the body of 
your comments and you must identify this information as 
``confidential.'' Any information marked as ``confidential'' will not 
be disclosed except in accordance with 21 CFR 10.20 and other 
applicable disclosure law. For more information about FDA's posting of 
comments to public dockets, see 80 FR 56469, September 18, 2015, or 
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Timothy McGrath, Staff Director, Food 
and Feed Laboratory Operations, Office of Regulatory Affairs, Food and 
Drug Administration, 12420 Parklawn Dr., Rm. 3142, Rockville, MD 20857, 
301-796-6591, email: [email protected].
    With regard to the information collection: Domini Bean, Office of 
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-5733, 
email: [email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of November 4, 2019 
(84 FR 59452), we published a proposed rule entitled ``Laboratory 
Accreditation for Analyses of Foods'' with a 120-day comment period on 
the provisions of the proposed rule and on the information collection 
provisions that are subject to review by the Office of Management and 
Budget (OMB) under the PRA (44 U.S.C. 3501-3521).
    FDA has received a request for a 30-day extension of the comment 
period on the proposed rule to allow interested persons additional time 
to consider the proposal. FDA has considered the request and is 
granting the extension of the comment period to allow interested 
persons additional opportunity to consider the proposal. We also are 
extending the comment period for the information collection provisions 
to make the comment period for the information collection provisions 
the same as the comment period for the provisions of the proposed rule. 
To clarify, FDA is requesting comment on all issues raised by the 
proposed rule. The Agency believes that this extension allows adequate 
time for any interested persons to fully consider the proposal and 
submit comments.

    Dated: February 21, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-03944 Filed 2-27-20; 8:45 am]
 BILLING CODE 4164-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.